HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevated [(18)F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson's disease.

Abstract
PET studies with the DOPA decarboxylase substrate 6-[(18)F]fluoro-l-DOPA (FDOPA) reveal the storage of [(18)F]-fluorodopamine within synaptic vesicles, mainly of dopamine fibres. As such, FDOPA PET is a sensitive indicator of the integrity of the nigrostriatal dopamine innervation. Nonetheless, there have been several reports of focal elevations of FDOPA utilization in brain of patients with Parkinson's disease (PD), all based on reference tissue methods. To investigate this phenomenon further, we used voxel-wise steady-state kinetic analysis to search for regions of elevated FDOPA utilization (K; ml g(-1) min(-1)) and steady-state trapping (V(d); ml g(-1)) in a group of well-characterized patients with early, asymmetric PD, who were contrasted with an age-matched control group. Subtraction of the population mean parametric maps revealed foci of increased FDOPA utilization K (+25%) in the bilateral medial nucleus accumbens, whereas the expected declines in the trapping of FDOPA were seen in the caudate and putamen. This observation suggests hyperfunction of catecholamine fibres innervating specifically the limbic striatum, which could guide the design of future prospective FDOPA-PET studies of the impulse control disorders occurring in some PD patients under treatment with dopamine agonists. A focus of increased FDOPA influx and also V(d) was detected in the periaqueductal grey, consistent with some earlier reports based on reference tissue analysis. Increased FDOPA trapping in the periaqueductal grey of PD patients seems consistent with recent reports of increased activity of serotonin neurons in a rat model of parkinsonism.
AuthorsYoshitaka Kumakura, Erik H Danielsen, Albert Gjedde, Ingo Vernaleken, Hans-Georg Buchholz, Andreas Heinz, Gerhard Gründer, Peter Bartenstein, Paul Cumming
JournalNeuroImage (Neuroimage) Vol. 49 Issue 4 Pg. 2933-9 (Feb 15 2010) ISSN: 1095-9572 [Electronic] United States
PMID19941962 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2009 Elsevier Inc. All rights reserved.
Chemical References
  • Radiopharmaceuticals
  • fluorodopa F 18
  • Dihydroxyphenylalanine
Topics
  • Adult
  • Aged
  • Dihydroxyphenylalanine (analogs & derivatives, pharmacokinetics)
  • Female
  • Humans
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Nucleus Accumbens (diagnostic imaging, metabolism)
  • Parkinson Disease (diagnostic imaging, metabolism)
  • Periaqueductal Gray (diagnostic imaging, metabolism)
  • Positron-Emission Tomography (methods)
  • Radiopharmaceuticals (pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: